These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 22514753

  • 41. Evaluation of the level of knowledge and compliance with standart precautions and the safety standard (NR-32) amongst physicians from a public university hospital, Brazil.
    La-Rotta EI, Garcia CS, Barbosa F, dos Santos AF, Vieira GM, Carneiro M.
    Rev Bras Epidemiol; 2013 Sep; 16(3):786-97. PubMed ID: 24896290
    [Abstract] [Full Text] [Related]

  • 42. Survey of Suspected Laboratory-Acquired Infections and Biosafety Practices in Research, Clinical, and Veterinary Laboratories in Karachi, Pakistan.
    Qasmi SA, Khan BA.
    Health Secur; 2019 Sep; 17(5):372-383. PubMed ID: 31593511
    [Abstract] [Full Text] [Related]

  • 43. Biosafety in beauty centers: knowledge and practices in a state capital in Northeast Brazil.
    Felipe IMA, Dias RDS, Couto CLL, Nina LNDS, Nunes SPH.
    Rev Gaucha Enferm; 2017 Sep; 38(4):e2016-3. PubMed ID: 29791534
    [Abstract] [Full Text] [Related]

  • 44. Compliance with standard precautions among operating room nurses in South Korea.
    Jeong I, Cho J, Park S.
    Am J Infect Control; 2008 Dec; 36(10):739-42. PubMed ID: 18945523
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G, Nisii C, Di Caro A, Brown D, Gopal R, Hewson R, Lloyd G, Gunther S, Eickmann M, Mirazimi A, Koivula T, Georges Courbot MC, Raoul H, Capobianchi MR.
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract] [Full Text] [Related]

  • 47. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA.
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [Abstract] [Full Text] [Related]

  • 48. Biosafety perspective of clinical laboratory workers: a profile of Pakistan.
    Nasim S, Shahid A, Mustufa MA, Arain GM, Ali G, Taseer IU, Talreja KL, Firdous R, Iqbal R, Siddique SA, Naz S, Akhter T.
    J Infect Dev Ctries; 2012 Aug 21; 6(8):611-9. PubMed ID: 22910567
    [Abstract] [Full Text] [Related]

  • 49. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K, Holbrook MR, Adams R, Barr J, Bollinger L, Newton JT, Ntiforo C, Coe L, Wada J, Pusl D, Jahrling PB, Kuhn JH, Lackemeyer MG.
    J Vis Exp; 2016 Oct 03; (116):. PubMed ID: 27768063
    [Abstract] [Full Text] [Related]

  • 50. Adherence to universal precautions among laboratory personnel in Lebanon.
    Kahhaleh JG, Jurjus AR.
    East Mediterr Health J; 2005 Oct 03; 11(5-6):929-42. PubMed ID: 16761663
    [Abstract] [Full Text] [Related]

  • 51. Biosafety considerations for autopsy.
    Nolte KB, Taylor DG, Richmond JY.
    Am J Forensic Med Pathol; 2002 Jun 03; 23(2):107-22. PubMed ID: 12040252
    [Abstract] [Full Text] [Related]

  • 52. [Biosafety in laboratories concerning exposure to biological agents].
    Vonesch N, Tomao P, Di Renzi S, Vita S, Signorini S.
    G Ital Med Lav Ergon; 2006 Jun 03; 28(4):444-56. PubMed ID: 17380946
    [Abstract] [Full Text] [Related]

  • 53. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
    van Soolingen D, Wisselink HJ, Lumb R, Anthony R, van der Zanden A, Gilpin C.
    Int J Tuberc Lung Dis; 2014 Aug 03; 18(8):885-9. PubMed ID: 25199000
    [Abstract] [Full Text] [Related]

  • 54. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN.
    Int J Antimicrob Agents; 2010 Nov 03; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [Abstract] [Full Text] [Related]

  • 55. Aseptic laboratory techniques: plating methods.
    Sanders ER.
    J Vis Exp; 2012 May 11; (63):e3064. PubMed ID: 22617405
    [Abstract] [Full Text] [Related]

  • 56. [Current biosafety in clinical laboratories in Japan: report of questionnaires' data obtained from clinical laboratory personnel in Japan].
    Goto M, Yamashita T, Misawa S, Komori T, Okuzumi K, Takahashi T.
    Kansenshogaku Zasshi; 2007 Jan 11; 81(1):39-44. PubMed ID: 17338315
    [Abstract] [Full Text] [Related]

  • 57. Biosafety considerations in laboratory design.
    Mortland KK, Mortland DB.
    Clin Leadersh Manag Rev; 2003 Jan 11; 17(3):175-7. PubMed ID: 12813961
    [No Abstract] [Full Text] [Related]

  • 58. WHO Laboratory Biosafety Manual: A New Approach to Security.
    Ficociello B, Giordano D, Incoronato F, Farinella A, Pietrangeli B.
    Ann Work Expo Health; 2023 Apr 21; 67(4):425-429. PubMed ID: 36495279
    [Abstract] [Full Text] [Related]

  • 59. Lessons to be Learned from Recent Biosafety Incidents in the United States.
    Weiss S, Yitzhaki S, Shapira SC.
    Isr Med Assoc J; 2015 May 21; 17(5):269-73. PubMed ID: 26137650
    [Abstract] [Full Text] [Related]

  • 60. [Adherence to standard precautions by the public pre-hospital health team in Belo Horizonte, Minas Gerais State, Brazil].
    Lopes AC, Oliveira AC, Silva JT, Paiva MH.
    Cad Saude Publica; 2008 Jun 21; 24(6):1387-96. PubMed ID: 18545764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.